Release Date: 10/03/16 16:51 Summary: Seventh Supplementary Bidder's Statement Price Sensitive: Yes Download Document 425.57KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%